BR0316059A - Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise - Google Patents
Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diáliseInfo
- Publication number
- BR0316059A BR0316059A BR0316059-9A BR0316059A BR0316059A BR 0316059 A BR0316059 A BR 0316059A BR 0316059 A BR0316059 A BR 0316059A BR 0316059 A BR0316059 A BR 0316059A
- Authority
- BR
- Brazil
- Prior art keywords
- fosinopril
- dialysis patients
- cardiovascular events
- reduce cardiovascular
- reduce
- Prior art date
Links
- 238000000502 dialysis Methods 0.000 title abstract 4
- BIDNLKIUORFRQP-XYGFDPSESA-N (2s,4s)-4-cyclohexyl-1-[2-[[(1s)-2-methyl-1-propanoyloxypropoxy]-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid Chemical compound C([P@@](=O)(O[C@H](OC(=O)CC)C(C)C)CC(=O)N1[C@@H](C[C@H](C1)C1CCCCC1)C(O)=O)CCCC1=CC=CC=C1 BIDNLKIUORFRQP-XYGFDPSESA-N 0.000 title abstract 3
- 229960002490 fosinopril Drugs 0.000 title abstract 3
- 230000007211 cardiovascular event Effects 0.000 title abstract 2
- 208000007177 Left Ventricular Hypertrophy Diseases 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
Abstract
"USO DE FOSINOPRIL PARA REDUZIR EVENTOS CARDIOVASCULARES EM PACIENTES DE DIáLISE". A invenção refere-se ao uso de fosinopril ou um sal farmaceuticamente aceitável do mesmo, para reduzir o risco de ocorrência de um evento cardiovascular em pacientes de diálise, em particular pacientes de diálise sang³ínea, especialmente pacientes apresentando hipertrofia ventricular esquerda.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0214060A FR2846886A1 (fr) | 2002-11-08 | 2002-11-08 | Utilisation de fosinopril pour diminuer les evenements cardiovasculaires chez des patients dialyses |
| PCT/EP2003/011147 WO2004041290A1 (en) | 2002-11-08 | 2003-10-09 | Use of fosinopril to reduce cardiovascular events in dialysis patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0316059A true BR0316059A (pt) | 2005-09-27 |
Family
ID=32116508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0316059-9A BR0316059A (pt) | 2002-11-08 | 2003-10-09 | Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20060135482A1 (pt) |
| EP (1) | EP1558267A1 (pt) |
| JP (1) | JP2006506405A (pt) |
| KR (1) | KR20050072480A (pt) |
| CN (1) | CN1708308A (pt) |
| AR (1) | AR042000A1 (pt) |
| AU (1) | AU2003278059A1 (pt) |
| BR (1) | BR0316059A (pt) |
| CA (1) | CA2505324A1 (pt) |
| FR (1) | FR2846886A1 (pt) |
| MX (1) | MXPA05004753A (pt) |
| PL (1) | PL374906A1 (pt) |
| WO (1) | WO2004041290A1 (pt) |
| ZA (1) | ZA200504652B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006100602A2 (en) * | 2005-03-22 | 2006-09-28 | Aurobindo Pharma Ltd | Immediate release stable solid oral dosage forms op fosinopril |
| BRPI0613704A2 (pt) * | 2005-07-08 | 2011-02-01 | Mochida Pharm Co Ltd | composição para impedir o inìcio e/ou a recorrência de eventos cardiovasculares |
| US20070087975A1 (en) * | 2005-10-17 | 2007-04-19 | Sigma-Tau Industrie Farmaceutiche Riunite Spa | Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients |
| SI23149A (sl) * | 2009-09-21 | 2011-03-31 | Silverstone Pharma | Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4931464A (en) * | 1989-02-15 | 1990-06-05 | E. R. Squibb & Sons, Inc. | Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation |
| WO2003013434A2 (en) * | 2001-08-06 | 2003-02-20 | Genomed, Llc | Methods and compositions for treating diseases associated with excesses in ace |
| IL163771A0 (en) * | 2002-02-28 | 2005-12-18 | Novartis Ag | N-ä5-Ä4-(4-methyl-piperazino-methyl benzoylamidoÜ--2-methylphenylü-4-(3-pyridyl)-2-pyrimidine-amine coated stents |
-
2002
- 2002-11-08 FR FR0214060A patent/FR2846886A1/fr active Pending
-
2003
- 2003-10-09 CN CNA2003801019861A patent/CN1708308A/zh active Pending
- 2003-10-09 CA CA002505324A patent/CA2505324A1/en not_active Abandoned
- 2003-10-09 EP EP03769362A patent/EP1558267A1/en not_active Withdrawn
- 2003-10-09 MX MXPA05004753A patent/MXPA05004753A/es not_active Application Discontinuation
- 2003-10-09 WO PCT/EP2003/011147 patent/WO2004041290A1/en not_active Ceased
- 2003-10-09 AU AU2003278059A patent/AU2003278059A1/en not_active Abandoned
- 2003-10-09 PL PL03374906A patent/PL374906A1/xx unknown
- 2003-10-09 US US10/534,052 patent/US20060135482A1/en not_active Abandoned
- 2003-10-09 BR BR0316059-9A patent/BR0316059A/pt not_active Application Discontinuation
- 2003-10-09 KR KR1020057008049A patent/KR20050072480A/ko not_active Withdrawn
- 2003-10-09 JP JP2004548734A patent/JP2006506405A/ja active Pending
- 2003-11-07 AR ARP030104096A patent/AR042000A1/es unknown
-
2006
- 2006-01-11 ZA ZA200504652A patent/ZA200504652B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR042000A1 (es) | 2005-06-08 |
| CN1708308A (zh) | 2005-12-14 |
| WO2004041290A1 (en) | 2004-05-21 |
| EP1558267A1 (en) | 2005-08-03 |
| JP2006506405A (ja) | 2006-02-23 |
| MXPA05004753A (es) | 2005-08-02 |
| KR20050072480A (ko) | 2005-07-11 |
| ZA200504652B (en) | 2006-03-29 |
| FR2846886A1 (fr) | 2004-05-14 |
| AU2003278059A1 (en) | 2004-06-07 |
| PL374906A1 (en) | 2005-11-14 |
| CA2505324A1 (en) | 2004-05-21 |
| US20060135482A1 (en) | 2006-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003009838A1 (en) | Use of stilbene compounds in preparing medicaments for treating or preventing diabetes and diseases associated with retrovirus | |
| BR9712523A (pt) | Novos derivados de pirazol heterociclilmetil-substituìdos | |
| BRPI0416628A (pt) | uso de compostos orgánicos | |
| TR200003333T2 (tr) | Ensülin direngenliği ve hiperglisemi tedavisinde yararlı benzotiyofenler | |
| EA200101156A1 (ru) | ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ | |
| SE9702860D0 (sv) | New use | |
| WO2004021968A3 (en) | Solution for ungual application | |
| DE69005347D1 (de) | Absaugkanüle für chirurgische Zwecke, insbesondere für Fettabsaugung. | |
| BR0116519B1 (pt) | cartucho de hemodiafiltraÇço/hemofiltraÇço de diluiÇço intermediÁria. | |
| BRPI0407234A (pt) | Heterociclos substituìdos | |
| BRPI0013924B8 (pt) | soluções farmacêuticas de levosimendano | |
| BRPI0409359A (pt) | análogos quiméricos de somatostatina-dopamina | |
| NO20000446D0 (no) | Anvendelse av fysiologisk akseptable vanadiumforbindelser, salter og komplekser | |
| WO2004006849A3 (en) | Combinations of drugs for the treatment of neoplasms | |
| ATE336243T1 (de) | Verwendung von l-carnitin und seinen alkanoyl- derivaten als osmotisches mittel in lösungen für medizinische verwendung | |
| DK1294379T3 (da) | En hidtil ukendt anvendelse af deferipron | |
| SE0102147D0 (sv) | New methods | |
| SE9900043D0 (sv) | New use | |
| BR0011578A (pt) | Utilização do s-enantiÈmero de citalopram para tratamento de distúrbio de ansiedade geral ou ataques de pânico | |
| BR9914644A (pt) | Composições tamponadas para diálise | |
| DK1643999T3 (da) | Pyridoxamin til anvendelse ved behandlingen af diabetisk nefropati ved type 2-diabetes | |
| EE200300129A (et) | Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine | |
| BR0316059A (pt) | Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise | |
| AU2001285944A1 (en) | Fungicidal agent containing n-chlorotaurine and use thereof | |
| CY1105317T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |